Shao Lee Lin Horizon Therapeutics Public LTD CO (HZNP) insider trading activity
Shao Lee Lin is EVP, Head of R&D and CSO of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 109,668 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Jan 21, 2020, when has been sold 2,716 shares (Ordinary Shares) at a price of $38.25 per share, resulting in proceeds of $103,887. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
110K
0%
3M change
0%
12M change
Total Value Held
$0
Shao-Lee Lin Transaction History
Also insider at
SL
Shao Lee Lin
EVP, Head of R&D and CSO
Dublin, L2